首页> 外文期刊>International Journal of Endocrinology and Metabolism >RECURRENCE OF HYPERPARATHYROID HYPERCALCEMIA IN A PATIENT WITH THE HRPT-2 MUTATION AND A PREVIOUS PARATHYROID CARCINOMA IN HYPERPARATHYROIDISM-JAW TUMOR SYNDROME
【24h】

RECURRENCE OF HYPERPARATHYROID HYPERCALCEMIA IN A PATIENT WITH THE HRPT-2 MUTATION AND A PREVIOUS PARATHYROID CARCINOMA IN HYPERPARATHYROIDISM-JAW TUMOR SYNDROME

机译:副甲状腺机能亢进-颌骨肿瘤综合征患者中HRPT-2突变和先前的副甲状腺副甲状腺癌患者的高副甲状腺高钙血症的复发

获取原文
           

摘要

Introduction: Cancer in the parathyroid gland is rare, but parathyroid cancer is occasionally seen in relation to genetic abnormalities.Due to a limited amount of evidence, the optimal handling of these cases is not clear. Furthermore, the presence of a malignant parathyroid tumor is rarely known at the time of the initial operation; therefore, re-operations are often necessary. The aim of this study was to present the case of a patient with a previously diagnosed jaw tumor and parathyroid carcinoma that presents as a recurrence of hyperparathyroid hypercalcemia.Case Presentation: A 41-year-old patient who was already diagnosed with a parathyroid carcinoma and a jaw tumor caused by a CDC73 mutation, presented with biochemical evidence of increasing parathyroid hormone (PTH) and calcium levels after a previous total parathyroidectomy. The patient’s ionized calcium increased to 1.55mmol/LandPTHincreased to 16.0 pmol/L.Aprevious genetic analysis revealed a mutation in the CDC73 gene. There was no family history of hyperparathyroidism. We performed a sestamibi scintigraphy and an 11-C methionine (MET) positron emission tomography (PET) scan that showed a recurrence on the left side of the trachea. Thepatientunderwenta third neck operation for the removal of atumoronthe left side of the trachea. Thepathology report revealed that the tumor was a lymph node metastasis from the previous parathyroid carcinoma. The patient is currently enrolled in our follow-up regime. Hyperparathyroidism-jaw tumor (HPT-JT) syndrome is a rare autosomal dominant disorder characterized by a parathyroid adenoma or carcinoma, fibro-osseous lesions (ossifying fibroma) of the mandible and maxilla, and renal cysts and tumors. This autosomal dominant familial cancer syndrome has been reported with a variable and incomplete penetrance, and up to 10% of gene carriers do not show any clinical manifestations. Here we present a patient’s case and discuss the literature related to this condition.Conclusions: The recurrence of hyperparathyroid hypercalcemia in HTP-JT syndrome after an initial total parathyroidectomy is a well-known condition necessitating careful management, an evaluation of any underlying genetic abnormality, and a family examination.A surgical treatment and surveillance of calcium and PTH measurements are necessary to prevent a recurrence.
机译:简介:甲状旁腺癌很少见,但偶发性甲状旁腺癌与遗传异常有关,由于证据有限,这些病例的最佳治疗方法尚不清楚。此外,在初次手术时很少发现恶性甲状旁腺肿瘤的存在。因此,经常需要重新操作。这项研究的目的是介绍一名先前诊断为颌甲肿瘤和甲状旁腺癌的患者,该病例表现为甲状旁腺高钙血症的复发。病例报告:一名41岁的患者已被诊断出甲状旁腺癌和由CDC73突变引起的下颌肿瘤,具有生化证据表明先前进行了全副甲状腺切除术后甲状旁腺激素(PTH)和钙水平增加。患者的离子钙升高至1.55mmol / L,PTH升高至16.0pmol / L。先前的遗传分析显示CDC73基因发生突变。没有甲状旁腺功能亢进症的家族史。我们进行了sestamibi闪烁显像和11-C甲硫氨酸(MET)正电子发射断层扫描(PET)扫描,结果显示气管左侧复发。病人进行了第三颈手术,以切除气管左侧的阴茎。病理报告显示,该肿瘤是先前甲状旁腺癌的淋巴结转移。该患者目前正在接受我们的随访方案。甲状旁腺功能亢进症(HPT-JT)综合征是一种罕见的常染色体显性遗传疾病,其特征是甲状旁腺腺瘤或癌,下颌骨和上颌骨的骨性纤维性病变(骨化性纤维瘤)以及肾囊肿和肿瘤。据报道,这种常染色体显性家族性癌症综合症的外貌变化多变且不完全,最多有10%的基因携带者未显示任何临床表现。结论:结论:初次全甲状旁腺切除术后HTP-JT综合征高甲状旁腺高钙血症的复发是众所周知的病状,需要仔细治疗,评估任何潜在的遗传异常,为了防止复发,必须进行外科手术治疗并监测钙和PTH的值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号